BCL2 and acute lymphoblastic leukemia: Elevated Bcl-2 expression neutralizes the pro-apoptotic effect of GC in ALL PDXs, and targeting the Bcl-2 signaling has demonstrated therapeutic effects in various types of ALL PDXs.